Dual-Energy X-Ray Absorptiometry Technical Issues: The 2007 ISCD Official Positions

Journal of Clinical Densitometry

Volumn 11, Issue 1, 2008, Pages 109-122

  Simonelli, Christine ^a,b   Adler, Robert A ^c   Blake, Glen M ^d   Caudill, JoAnn P ^e   Khan, Aliya ^f   Leib, Ed ^g   Maricic, Michael ^h   Prior, Jerilynn C ⁱ   Eis, Sergio Ragi ^j   Rosen, Cliff ^k   Kendler, David L ^l  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

^d GUY S HOSPITAL   (United Kingdom)

^e Erickson Retirement Communities   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF VERMONT   (United States)

^h Catalina Pointe Arthritis and Rheumatology Specialists   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j CEDOES   (Brazil)

^k ST JOSEPH HOSPITAL   (United States)

^l Prohealth Clinical Research   (Canada)

more..

Author keywords

Dual energy X ray absorptiometry; high bone density; male osteoporosis; osteoporosis risk factors; perimenopause

Indexed keywords

ARTICLE; BODY MASS; BONE DENSITOMETRY; CLIMACTERIUM; DIAGNOSTIC ACCURACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; MEDICAL SOCIETY; MENOPAUSE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 42949084208     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2007.12.009     Document Type: Article

References (124)

1. Leslie W.D., Adler R.A., El-Hajj Fuleihan G., et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom 9 1 (2006) 22-30
2. Kanis J.A., Johnell O., Oden A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 16 (2005) 222-228
3. Kanis J.A., Johansson H., Johnell O., et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 16 (2005) 737-742
4. Kanis J.A., Johnell O., De Laet C., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 (2004) 375-382
5. Kanis J.A., Johansson H., Oden A., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 (2004) 893-899
6. Smith M.R., Lee W.C., Brandman J., et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol 23 31 (2001) 7897-7903
7. Smith M.R., Boyce S.P., Myneur E., et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 175 1 (2006) 136-139
8. Greenspan S.L., Coates P., Sereika S.M., et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 90 20 (2005) 6410-6417
9. Stoch S.A., Parker R.A., Chen L., et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 86 6 (2001) 2787-2791
10. Eastell R. Pathogenesis of postmenopausal osteoporosis. In: Favus M.J. (Ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. (2003), American Society for Bone and Mineral Research, Washington, DC 314-316
11. Abrahamsen B., Nissen N., Hermann A.P., et al. When should densitometry be repeated in healthy peri- and postmenopausal women? The Danish Osteoporosis Prevention Study. J Bone Miner Res 17 (2002) 2061-2067
12. Smeets-Goevaers C.G., Lelusink G.L., Papapoulos S.E., et al. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporos Int 8 5 (1998) 404-409
13. th ed. (2003), American Society for Bone and Mineral Research, Washington, DC 449 [470-477]
14. Cherian R.A., Haddaway M.J., Davie M.W., et al. Effect of Paget's disease of bone on areal lumbar spine bone mineral density measured by DXA, and density of cortical and trabecular bone measured by quantitative CT. Br J Radiol 73 871 (2000) 720-726
15. White M.P. Misinterpretation of osteodensitometry with high bone density. J Clin Densitom 8 1 (2005) 1-6
16. Pappou I.P., Firardi F.P., Sandhu H.S., et al. Discordantly high spinal bone mineral density values in patients with adult lumbar scoliosis. Spine 31 14 (2006) 1614-1620
17. Guglielmi G., Floriani I., Torri V., et al. Effect of spinal degenerative changes on volumetric bone mineral density of the central skeleton as measured by quantitative computed tomography. Acta Radiol 46 3 (2005) 269-275
18. Yu W., Gluer C.C., Fuerst T., et al. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57 3 (1995) 169-174
19. Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom 7 1 (2004) 17-26
20. Kanis JA, Oden A, Johnell O, et al. 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteo Int, in press.
21. Seeman E., Bianchi G., Khosla S., et al. Bone fragility in men-where are we?. Osteoporos Int 17 (2006) 1577-1583
22. Cummings S.R., Cawthon P.M., Ensrud K.E., et al., for the Osteoporotic Fractures in Men (MrOS) and Study of Osteoporotic Fractures (SOF) Research Groups. BMD and Risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21 (2006) 1550-1556
23. Melton L.J. Epidemiology of fractures. In: Riggs B.L., and Melton L.J. (Eds). Osteoporosis: Etiology, Diagnosis and Management. 2nd ed. (1995), Lippincott-Raven press, Philadelphia 225-247
24. Kanis J.A., Johansson H., Oden A., et al. A family history of fracture and fracture risk. Bone 35 (2004) 1029-1037
25. Recker R., Lappe J., Davies K., et al. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15 (2000) 1965-1973
26. Randolph Jr. J.F., Sowers M., Gold E.B., et al. Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab 88 4 (2003) 1516-1522
27. Chapurlat R.D., Gamero P., Sornay-Rendy E., et al. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 11 6 (2000) 493-498
28. Steinberg K.K., Freni-Titulaer L.W., DePuey E.G., et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69 3 (1989) 533-539
29. Rannevik G., Jeppsson S., Johnell O., et al. a longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21 2 (1995) 103-113
30. Sirola J., Kroger H., Honkanen R., et al. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?. Osteoporos Int 14 1 (2003) 27-33
31. Bergstrom I., Freyschuss B., and Landgren B.M. Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int 16 7 (2005) 823-828
32. Heinonen A., Oja P., Sioevanen H., et al. Effect of two training regimens on bone mineral density in healthy perimenopausal women: a randomized controlled trial. J Bone Miner Res 13 3 (1998) 483-490
33. Sirola J., Rikkonen T., Tuppurainen M., et al. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study. Calcif Tissue Int 78 4 (2006) 218-226
34. Bainbridge K.E., Sowers M., Lin X., et al. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 15 6 (2004) 439-446
35. Holm K., Dan A., Wilbur J., et al. A longitudinal study of bone density in midlife women. Health Care Women Int 23 6-7 (2002) 678-691
36. Cooper L., Clifton-Bligh P.B., Nery M.L., et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 77 5 (2003) 1324-1329
37. Patel R., Blake G.M., and Fogelman I. Peripheral and central measurement of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Calcif Tissue Int 80 2 (2007) 89-96
38. Van der Voort D.J., Geusens P.P., and Dinant G.J. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int 12 8 (2001) 630-638
39. Siris E.S., Miller P.D., Barrett-Connor E., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286 22 (2001) 2815-2822
40. Bauer D.C., Browner W.S., Cauley J.A., et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118 (1993) 657-665
41. Law M.R., and Hackshaw A.K. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315 (1997) 841-846
42. Ebeling P.R., Atley L.M., Guthrie J.R., et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81 9 (1996) 3355-3371
43. Iki M., Morita A., Ikeda Y., et al., for the JPOS Study Group. Biochemical markers of bone turnover may predict progression to osteoporosis in osteopenic women: the JPOS Cohort Study. J Bone Miner Metab 25 2 (2007) 122-129
44. Mallmin H., Ljunghall S., Persson I., et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years follow-up. Calcif Tissue Int 52 (1993) 269-272
45. Klotzbuecher C.M., Ross P.D., Landsman P.B., et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15 (2000) 721-727
46. Aloia J.F., Cohn S.H., Vaswani A., et al. Risk factors for postmenopausal osteoporosis. Am J Med 78 (1985) 95-100
47. Wasnich R.D., Davis J.W., and Ross P.D. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int 4 (1994) 1-5
48. Black D.M., Arden N.K., Palermo L., et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14 (1999) 821-828
49. Honkanen M., Tuppurainen M., Kroger H., et al. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 60 4 (1997) 327-331
50. Barrett-Connor E., Slone S., Greendale G., et al. The postmenopausal estrogen/progestin intervention study: primary outcomes in adherent women. Maturitas 27 3 (1997) 261-274
51. Hosking D., Chilvers C.E.D., Christiansen C., et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 338 (1998) 485-492
52. Ravn P., Weiss S.R., Rodriguez-Portales J.A., et al. Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group. J Clin Endocrinol Metab 85 (2000) 1492-1497
53. Mortensen L., Charles P., Bekker P.J., et al. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 83 (1998) 396-402
54. Jolly E.E., Bjarnason N.H., Neven P., et al. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause 10 (2003) 337-344
55. McClung M.R., Wasnich R.D., Recker R., et al. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res 19 (2004) 11-18
56. Siris E.S., Brenneman S.K., Barrett-Connor E., et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 17 4 (2006) 565-574
57. Siris E.S., Brenneman S.K., Miller P.D., et al. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res 19 8 (2004) 1215-1220
58. NIH Consensus Development Conference Statement, March 2000: Osteoporosis Prevention, Diagnosis and Therapy. Available at: http://consensus.nih.gov/2000/2000Osteoporosis111html.htm.
59. Kanis J.A., Johnell O., Oden A., et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. J Bone Miner Res 16 (2001) S194
60. Sowers M., Zheng H., Tomey K., et al. Changes in body composition in women over six years at mid-life: ovarian and chronological aging. J Clin Endocrinol Metab 92 3 (2007) 895-901
61. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. [Technical Report Series No. 843] (1994), WHO, Geneva, Switzerland
62. Binkley N., Bilezikian J.P., Kendler D.L., et al., International Society for Clinical Densitometry. Official positions of the International Society and Executive summary of the 2005 Position Development Conference. J Clin Densitom 9 1 (2006) 4-14
63. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis (2003), National Osteoporosis Foundation, Washington, DC. Available at: www.nof.org
64. Kocher M.S., and Kasser J.R. Osteopetrosis. Am J Orthop 32 5 (2003) 222-228
65. Brown J.P., and Josse R.G. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 167 10 Suppl (2002) S1-S34
66. Ott S. Osteoporosis and bone physiology. Available at: (2007). http://courses.washington.edu/bonephys/opbmd.html [Used with permission]
67. http://en.wikipedia.org/wiki/Carl_Friedrich_Gauss
68. http://en.wikipedia.org/wiki/Normal_distribution
69. Bonnick S.L., and Lewis L.A. Bone densitometry for technologists. 2nd ed. (2006), Humana Press, New Jersey
70. Blake G.M., and Fogelman I. The role of DXA scanning in the diagnosis and treatment of osteoporosis. J Clin Densitom 10 (2007) 102-110
71. Melton III L.J., Atkinson E.J., O'Fallon W.M., et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 10 (1993) 1227-1233
72. Krege J.H., Miller P.D., Lenchik L., et al. New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status. J Clin Densitom 9 2 (2006) 144-149 [Epub May 2, 2006]
73. Smith J.A., Vento J.A., Spencer R.P., et al. Aortic calcification contributing to bone densitometry measurement. J Clin Densitom 2 2 (1999) 181-183
74. Blake GM. Unpublished reference data for 7000 UK women.
75. Faulkner K.G., Von Stetton E., and Miller P. A list of device specific thresholds for the clinical interpretation of peripheral X-ray absorptiometry examinations. Osteoporos Int 16 (1999) 2149-2156
76. Blake G.M., Chinn D.J., Steel S.A., et al. A list of device specific thresholds for the clinical interpretation of peripheral X-ray absorptiometry examinations. Osteoporos Int 16 (2005) 2149-2156
77. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8 (1998) 468-489
78. Chavassieux P., Seeman E., and Delmas P.D. Insights into material and structural basis of bone fragility from diseases associated with fractures. Endocr Rev 28 2 (2007) 151-164
79. Shapiro F. Osteopetrosis: current clinical considerations. Clin Orthop (1993) 33-44
80. Tolar J., Teitelbaum S.L., and Orchard P.J. Osteopetrosis. N Engl J Med 351 27 (2004) 2839-2849
81. Simonelli C, Sinner PJ, Schoeller, MC. Prevalence of high bone mineral density T-scores in a community population. Poster presentation T455 ASBMR, 2007; Abstract JBMR 2007.
82. Whyte M.P. Skeletal disorders characterized by osteosclerosis or hyperostosis. In: Avioli L.V., and Krane S.M. (Eds). Metabolic Bone Disease and Clinically Related Disorders. 3rd ed. (1998), Academic Press, San Diego, CA 697-738
83. Rand T., Seidl G., Kainberger F., et al. Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy X-ray absorptiometry (DXA). Calcif Tissue Int 60 (1997) 430-433
84. Liu G., Peacock M., Eilam O., et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 7 (1997) 564-569
85. Peel N.F.A., Johnson A., Barrington N.A., et al. Impact of anomalous vertebral segmentation of measurements of bone mineral density. J Bone Miner Res 8 (1993) 719-723
86. Bonnick S.L. Bone Densitometry in Clinical Practice. 2nd ed. (2004), Humana Press, New Jersey 37
87. Davis J.W., Grove J.S., Wasnich R.D., et al. Spatial relationships between prevalent and incident fractures. Bone 24 (1999) 261-264
88. Lang T.F., Guglielmi G., van Kuijk C., et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30 1 (2002) 247-250
89. Dugan L.O., Dugan D.A., and Dugan Jr. W.M. Back Pain: the primrose path-a case report. Indiana Med 83 2 (1990) 114-116
90. Nevitt M.C., Lane N.E., Scott J.C., et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38 (1995) 907-916
91. Lu P.W., Briody J.N., Ogle G.D., et al. Bone mineral density of total body, spine and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res 9 (1994) 1451-1458
92. Frye M.A., Melton L.J., Bryant S.C., et al. Osteoporosis and calcification of the aorta. J Bone Miner Res 19 (1992) 185-194
93. Frohn J., Wilken T., Falk S., et al. Effect of aortic sclerosis on bone mineral measurements by dual-photon absorptiometry. J Nucl Med 32 (1990) 259-262
94. Orwoll E.S., Oviatt S.K., and Mann T. Effect of aortic sclerosis on bone mineral measurements by dual-photon absorptiometry. J Nucl Med 32 (1990) 259-262
95. Drinka P.J., DeSmet A.A., Bauwens S.F., et al. The effect of overlying calcification on lumbar bone densitometry. Calcif tissue Int 50 (1992) 507-510
96. Shankar S., and Hosking D.J. Biochemical assessment of Paget's Disease of Bone. J Bone Miner Res 21 Suppl 2 (2006) 22-27
97. Laroche M., Delpech B., Bernard J., et al. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment. Calcif Tissue Int 65 3 (1999) 188-191
98. Henriksen K., Gram J., Hoegh-Andersen P., et al. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T2531 mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol 167 5 (2005) 1341-1348
99. Schilling A.F., Mulhausen C., Lehmann W., et al. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K. Osteoporos Int 18 5 (2007) 659-669
100. Nora E.H., Kennel K.A., and Christian R.C. Traumatic fracture in a healthy man: benign or pathologic?. Endocr Pract 12 5 (2006) 552-558
101. Kurland E.S., Schulman R.C., Zerwekh J.E., et al. Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res 22 1 (2007) 163-170
102. Boivin G., Chavassieux P., Chapuy M.C., et al. Histomorphotmetric profile of bone fluorosis induced by prolonged ingestion of Vichy Sanit-Yorre water. Comparison with bone fluorine levels. Pathol Biol (Paris) 34 1 (1986) 33-39
103. Tamer M.N., Kale K.B., Arsian C., et al. Osteosclerosis due to endemic fluorosis. Sci Total Environ 373 1 (2007) 43-48 [Epub Dec 19, 2006]
104. Bouletreau P.H., Bost M., Fontanges E., et al. Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition. Am J Clin Nutr 83 6 (2006) 1429-1437
105. Frame B., Honasoge M., and Kottamasu S.R. Osteosclerosis, Hyperostosis and Related Disorders (1987), Elsevier, New York, NY
106. Whyte M.P. High bone mass disease. In: Kleerekoper M., Sirus E., and McClung M. (Eds). The Bone and Mineral Manual: A Practical Guide. 2nd ed. (2004), Academic Press, San Diego, CA
107. Albers-Schonberg H. Rontgenbilder einer siltenen, Knochenerkrankung. Munch Med Wochenschr 51 (1904) 365
108. Resnick D., and Niwayama G. Diagnosis of Bone and Joint Disorders. 3rd ed. (1995), WB Saunders, Philadelphia
109. Johnston Jr. C.C., Lavy N., Lord T., et al. Osteopetrosis: a clinical, genetic, metabolic and morphologic study of the dominantly inherited, benign form. Medicine 47 (1968) 149-167
110. Bollerslev J. Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical and hormonal aspects. Endocr Rev 10 (1989) 45-67
111. Loria-Cortes R., Quesada-Calvo E., and Cordero-Chaverri E. Osteopetrosis in children: a report of 26 cases. J Pediatr 91 (1977) 43-47
112. Whyte M.P. Skeletal disorders characterized by osteoclerosis or hyperostosis. In: Avioli L.V., and Krane S.M. (Eds). Metabolic Bone Disease. 2nd ed. (1997), Academic Press, San Diego 697-738
113. Whyte M.P. Sclerosing bone disorders. In: Favus M.J. (Ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. (1999), Lippincott Williams & Wilkins, Philadelphia
114. Khosla S., Hassoun A.A.K., Baker B.K., et al. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis: a means to increase bone mass in adults?. J Clin Invest 101 (1998) 2165-2173
115. Koay M.A., Woon P.Y., Zhang Y., et al. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19 10 (2004) 1619-1627
116. Nelson R.L., Turyk M., Kim J., et al. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 12 1 (2002) 22
117. Nelson R.L., Turky M., Kim J., et al. Bone mineral density and subsequent risk of prostate cancer in the NHANES I follow-up. IARC Sci Publ 156 (2002) 319-321
118. Crandall C., Palla S., Reboussin B.A., et al. Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res 7 6 (2005) R922-R928
119. Ganry O., Tramier B., Fardellone P., et al. High bone-mass density as a marker for breast cancer in post-menopausal women. Breast 10 (2001) 313-317
120. Zmuda M., Cauley J.A., Ljung B.M., et al., for the Study of Osteoporotic Fractures Research Group. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93 12 (2001) 930-936
121. Nguyen T.V., Center J.R., and Eisman J.A. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 36 (2000) 27-34
122. Kerlikowske K., Shepherd J., Creasman J., et al. Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst 97 5 (2005) 368-374
123. Vandevord P.J., Wooley P.H., Darga L.L., et al. Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 100 1 (2006) 103-107
124. Simberg N., Tiitinen A., Silfvast A., et al. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement. J Clin Endocrinol Metab 81 2 (1996) 646-651